Additionally, because we focused on the 24 h reperfusion time point, when kidney damage had begun and was accompanied by a clear window between ACSL4 levels in Mlkl-knockout and wt mice, we stopped the therapy with 16–86 24 h after the onset of reperfusion. The gene discussed is ACSL4; the disease is Nephropathy.